• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Is anyone else experiencing burnout?









not the OP, but my understanding is that the cstyx nurses will be cross-training on gilenya and not at all happy about it, given the state of the msbu.
i've also heard that it's hard enough to get a job in the nurse educator field post-NVS, but nearly impossible if you've been associated with that drug
 








not the OP, but my understanding is that the cstyx nurses will be cross-training on gilenya and not at all happy about it, given the state of the msbu.
i've also heard that it's hard enough to get a job in the nurse educator field post-NVS, but nearly impossible if you've been associated with that drug

They are dropping like flies. Some leaving for any job at all to gain some distance from this place
 












Here s a thought..........Maybe entresto just isn't that great. Commercial s,overlays, people run off. The market has decided. It's been a year. Entresto is a small product that will only help a small number of people.